drugset / Trial / NCT05813951
Efficacy and Safety of Continuous Versus Intermittent Linezolid Infusion in Critically Ill Patients With Septic Shock
RandomizedParallel-groupDouble-blindTreatment
Summary
The aim of study is this to evaluate the efficacy and safety of continuous linezolid infusion versus the standard regimen in treating critically ill patients with septic shock in the ICU
Timeline
- Start
- 2022-12-02
- Primary completion
- 2023-12-02
- Completion
- 2023-12-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Linezolid | Other / unclassified | 600 mg | Intravenous |
| Comparator | Linezolid | Other / unclassified | 1200 mg | Intravenous |
Indications
No indication recorded.